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Abstract
Krebs cycle disorders constitute a group of rare human diseases which present an amazing complexity considering our
current knowledge on the Krebs cycle function and biogenesis. Acting as a turntable of cell metabolism, it is ubiquitously
distributed in the organism and its enzyme components encoded by supposedly typical house-keeping genes. However, the
investigation of patients presenting specific defects of Krebs cycle enzymes, resulting from deleterious mutations of the
considered genes, leads to reconsider this simple envision by revealing organ-specific impairments, mostly affecting
neuromuscular system. This often leaves aside organs the metabolism of which strongly depends on mitochondrial energy
metabolism as well, such as heart, kidney or liver. Additionally, in some patients, a complex pattern of tissue-specific
enzyme defect was also observed. The lack of functional additional copies of Krebs cycle genes suggests that the complex
expression pattern should be ascribed to tissue-specific regulations of transcriptional andror translational activities, together
with a variable cell adaptability to Krebs cycle functional defects. q 1997 Elsevier Science B.V.
1. Introduction
 .1992: ’This pathway i.e. the Krebs cycle is so
crucial to the metabolism of living cells that any
w xsignificant defect is incompatible with life’ 1 . Ac-
cordingly, enzyme defects affecting the Krebs cycle,
 .also known as the tricarboxylic acid cycle TCAC ,
were for long considered as highly unlikely. Thus,
even the disclosure of a high fumaric aciduria in
patients was not sufficient to prompt authors in the
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.eighties to measure fumarase activity: ’since it is
very probable that the concomitant failure of oxida-
tive metabolism associated with the TCAC would
have catastrophic physiological and clinical conse-
w xquences’ 2 .
However, although rare diseases less than 25
.cases reported in the literature , defects affecting one
or more of the TCAC enzymes have been now
convincingly established. For the sake of comparison,
 .on 1300 young patients 0–15 yr investigated in our
laboratory, we identified 6 cases with a TCAC en-
zyme defect compared to 220 cases with a respiratory
chain enzyme defect. In the three last years, the
molecular bases were elucidated in the case of two of
0925-4439r97r$17.00 q 1997 Elsevier Science B.V. All rights reserved.
 .PII S0925-4439 97 00035-5
( )P. Rustin et al.rBiochimica et Biophysica Acta 1361 1997 185–197186
these inherited metabolic diseases, namely fumarase
w xand succinate dehydrogenase deficiencies 3,4 .
2. A multi-functional cycle
Since its formalization by Hans Adolf Krebs in
1937, the TCAC, also known as the Krebs cycle, has
w xproved to be a major turntable of cell metabolism 5 .
The conversion of the reducing power accumulated
into carbon compounds to the respiratory chain-usa-
ble reduced coenzymes, NADH and FADH , consti-2
tutes the major function of the TCAC. However, it
also ensures a central role in the intermediary
metabolism through the breakdown of acetyl-CoA
and through the interconversion of carbon skeletons
 .required for several anaplerotic pathways Fig. 1 .
Moreover, TCAC should also be considered as a
water splitting process generating oxygen for glucose
w xoxidation and CO production 6 . Two reactions of2
the TCAC consume one H O molecule each furnish-2
ing oxygen for CO generation and oxidative reac-2
Fig. 1. Enzymes, reactions and integration in cell metabolic pathways of the Krebs cycle.
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tions, namely the combination between acetyl-CoA
and oxaloacetate to form citrate and the formation of
malate from fumarate. Atmospheric oxygen is only
used for the reoxidation of reduced coenzymes by the
respiratory chain.
The TCAC is constituted by a series of 8 biochem-
ical reactions that lead to the progressive oxidative
decarboxylation of the acetyl CoA, mostly resulting
from the activity of the pyruvate dehydrogenase Fig.
.1 . Beside pyruvate from the glycolysis, the TCAC
can be fed by carbon compounds derived from fatty
acid degradation or from the several amino-acids
 .glutamate, alanine, etc. . This traditional view of the
TCAC functioning has nevertheless been challenged
Table 1
The enzymes of the Krebs cycle
Mitochondrial TCAC Alternative Chromosomal location Cytosolic isoenzyme
 .enzymes terms D-segment
 .available human cDNA
Citrate synthase CS 12p11)qter
  .E.C. 4.1.3.7 Homodimer y
NAD-dependent isocitric a , b and g IDH-M a subunit 15q11)qter
 .dehydroge-nase subunits D15S114-D15S206
 .E.C. 1.1.1.41 g subunit Xqter
 .DXS1193-Xqter
Heterotetramer
 .q; a and g subunits
NADP-dependent IDH2 15q21)qter Homodimer; IDH1
isocitric dehydrogenase
  .E.C. 1.1.1.42 Homodimer q
Aconitase ACO2 22q11)q13 Monomomer, ACO1
 .D22S1171-D22S428
 .  .E.C. 4.2.1.3 Monomer y
 .a-ketoglutarate E1k E.C. 1.2.4.2 Oxoglutarate 7q13)p11.2
 .dehydrogenase D7S667-D7S2427
dehydrogenase, additional copy: 10
 .OGDH q
 .E2k E.C. 2.3.1.61 Dihydrolipoyl 14q24.2)q24.3
 .D14S71-D14S76
succinyltransferase, additional copy: 1p31
 .DLST q
 .  .E3 E.C. 1.8.1.4 Dihydrolipoyl 7q31)q32 D7S2459-D7S692
 .dehydrogenase DLD q
 .Succinyl-CoA synthetase a and b subunits succinate thiokinase b subunit 13
 .D13S263-D13S155
 .GDP forming succinyl CoA ligase y
 .EC 6.2.1.4 heterodimer
Succinate dehydrogenase iron-sulfur subunit IP SDH, SDH1 1p35)p36.1
 .  .EC 1.3.99.1 Heterodimer q
 .flavoprotein FP SDH, SDH2 5pter D5S392
additional copy: 3q29
 .Fumarate hydratase fumarase, FH2 1q42.1 D1S204 Homotetramer; FH1
 .E.C. 4.2.1.2 additional copies: 5 and 13
 .NAD-dependent MDH2, M-MDH 7q13)q22 D7S675-D7S669 Homodimer; MDH1,
malate dehydrogenase C-MDH
 .  .EC 1.1.1.37 y
Chromosomal locations were derived from release 96.0 of GenBank
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Fig. 2. Model for a functional splitting of the Krebs cycle
reactions into complementary mini-cycles. The functioning of the
 .first mini-cycle A would allow to convert pyruvate up to a-KG,
 .even when the second mini-cycle B does not function. This
could account for the urinary excretion of a-KG in patients
presenting with defect of a-KG, SDH or fumarase activity.
Similarly, it could produce reduced equivalents to sustain the
normal oxygen uptake measured in circulating lymphocytes or
cultured skin fibroblast from these patients.
in order to account for the complexity and the variety
of the physiological contexts encountered in living
cells. TCAC-related enzyme equipment of mitochon-
dria may vary between species, and, in one given
species, between organs. Thus mitochondria endowed
with matrix malic enzyme can use malate as unique
fuel molecule for TCAC running, malate being then
used as a source of both pyruvate and oxaloacetate
 .OAA through the reactions catalysed by the malic
enzyme and the malate dehydrogenase respectively
w x7,8 . On the other hand, the unity of the cycle has
been questioned and some suggestions have been
made that it is actually comprised of 2 independent
segments, allowing different fluxes, extending from
a-KG to OAA and from OAA to a-KG, respectively
w x9 . Working in close connection with the aspartate-
 .amino acid transferase AAT, which produces a-KG ,
these would constitutes ’mini-Krebs cycles’ consum-
ing or producing glutamate and aspartate, requiring
 .only catalytic amounts of OAA or of a-KG Fig. 2 .
The TCAC takes place in the semi-fluid matrix
space of the mitochondria where metabolically-re-
lated enzymes appear to be associated into metabolons
ensuring channelling of substrates through selected
w xsets of enzymes 10 . Accordingly, the TCAC en-
zymes are consistently found in balanced proportions
w xin different tissues 11 , suggesting a concerted ex-
pression of the genes coding for TCAC enzymes. The
semi-fluid state of the matrix also favours a kinetic
compartmentation of soluble oxidation cofactors, such
w xas nicotinamide adenine dinucleotides 12 , together
with the several dehydrogenases.
Citrate synthase, isocitrate and a-KG dehydroge-
nases are generally considered as important regula-
tory steps controlling the flux through the entire cycle
w x1 . The pyridine nucleotide redox poise
 .NADHrNADq , the matrix phosphorylation po-
 . 2qtential PiqADPrATP ratio and the Ca concen-
trations act as major regulatory factors controlling
several steps of the TCAC.
Finally, a wealth of evidences has been provided
showing that thyroid hormones and glucocorticoids
w xinfluence the activity of the TCAC cycle 13,14 . On
one hand, thyroid hormone-induced increase of mito-
chondrial Ca2q and substrate supply would stimulate
w xthe overall TCAC activity 13 . On the other hand,
control of mitochondrial biogenesis by thyroid hor-
mones and glucocorticoids, exerted at both transcrip-
tional and translational levels, would account for
broader term effect of hormones on TCAC activity
w x13,14 .
The TCAC enzymes are all nuclearly-encoded.
 .Most of the nuclear genes 11 on 15 encoding the
protein moieties constitutive of the 9 TCAC mito-
chondrial enzymes have now been localized in man
and 9 of the corresponding cDNAs have been cloned
 .and sequenced Table 1 . Four of the TCAC enzymes
possess both a mitochondrial and a cytosolic isoen-
 .zyme Table 1 . In the particular case of fumarase,
both isoenzymes have been shown to be encoded by
a single gene, which raises intriguing questions upon
the mechanism controlling their sub-cellular distribu-
w xtion 15 .
3. Krebs cycle diseases
Few cases of isolated and supposedly primary
Krebs cycle disorders have been reported in human.
Deficiencies of a-KG dehydrogenase, succinate de-
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 .hydrogenase SDH and fumarase were reported in 3,
 .7 and 14 patients, respectively Table 2 . Beside
these specific enzyme defects, enzymes of the TCAC
can be affected concurrently with enzymes involved
in other metabolic pathways. Thus, a defect of the
dihydrolipoamide dehydrogenase the E component3
.of the 2-ketoacid dehydrogenases characteristically
associates a defective activity of the pyruvate and the
branched-chain amino acid dehydrogenases together
w xwith a decreased a-KG dehydrogenase activity 33 .
A decrease of both aconitase and SDH has also been
reported in one patient presenting with generalized
defect of iron-sulfur proteins, including rhodanese,
the Rieske protein of the complex III and several
subunits of the complex I of the respiratory chain
w x34 .
Among the major clinical features encountered in
patients presenting isolated TCAC enzyme defects,
neurological impairments - associated or not with
muscular involvement - are prominent figures, being
 .encountered in 19r22 cases 85% , with en-
 .cephalopathy 11 cases and typical Leigh syndrome
 .1 case being reported in 70% of the documented
 .cases Table 2 . Hypertrophic cardiomyopathy, iso-
 . lated 1 case or part of a pluritissular disease 4
.cases , has also been reported in 18% of the cases, all
of them presenting with a SDH deficiency, except for
one case presenting with a-KG dehydrogenase defi-
w xciency 17 . Interestingly enough, no cardiac involve-
ment was reported for any of the patients presenting
 .with a fumarase deficiency Table 2 .
The age of onset of fumarase and a-KG dehydro-
genase deficiencies was consistently below 1 y of
age, with hypotonia, failure to thrive andror lactic
acidosis being frequently first noticed. In contrast,
patients with SDH deficiencies were often diagnosed
w xafter several years of life 19 or even in adulthood
w x20,23 . Onset symptoms associated with SDH defi-
ciencies vary from case to case, among them growth
retardation, pulmonary oedema, bronchiolitis, body
rigidity or optic atrophy. Although not consistently,
the latter onset and the milder outcome noticed for
SDH-deficient patients correspond to relatively higher
 .enzyme residual activities Table 2 .
An abnormal urinary excretion of organic acids
was frequently noticed in those patients with TCAC
enzyme deficiencies, with occasional peaks of a-KG
observed whatever the enzyme deficiency a-KG
.dehydrogenase, SDH, or fumarase . Obviously due to
the enzyme defect in cases of a-KG dehydrogenase
deficiencies, this a-KG excretion might result from
the secondary blockade of this enzyme by succinyl
CoA in the case of SDH and fumarase deficiencies
 .see Fig. 1 . The excretion of a-KG is also an
indication that at least a segment of the TCAC me-
tabolizes pyruvate. This possibly accounts as well for
the inconsistency of the lactic acidosis and the mild,
if any, elevation of LrP ratios measured in these
patients.
4. Biochemical, molecular findings and genetics
As mentioned above, while profound defects of
fumarase both cytosolic and mitochondrial isoen-
.zymes and a-KG dehydrogenase have often been
 .reported less than 1% in vitro residual activity , only
partial SDH defects have been reported more than
.25% in vitro residual activity . Incidentally, it is
noteworthy that the profound defects of TCAC en-
zymes only concern enzymes involved in one of the
mini-Krebs cycle suggesting an activation of an in
vivo metabolic by-pass allowing cell survival Fig.
.2 . Accordingly, normal respiration rates have been
consistently observed in the enzyme deficient cells
circulating lymphocytes and cultured skin fibrob-
. w xlasts of these patients 3,35 .
SDH deficiencies are also distinct by their variable
tissue-specific expression which was observed in three
w xof the cases reported 21,23,24 . This was somewhat
surprising considering that the products of the
house-keeping TCAC genes are essentially dis-
tributed among all human tissues. No functional addi-
tional copies of Krebs cycle genes have been reported
so far, suggesting that the tissue-specific expression
pattern should rather be ascribed to tissue-specific
regulations of transcriptional andror translational ac-
tivities.
Identification of mutations causing TCAC enzyme
deficiencies have been now reported for both fu-
w x w xmarase 3,34 and SDH 4 . A mutation in the fu-
marase cDNA was first reported in two siblings with
progressive encephalopathy and fumarase deficiency
w x3 . Both patients were found homozygous for a
missense mutation, a G955C transversion, predicting
a Glu319Gln substitution in a highly conserved do-
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main of the protein. Both first cousin parents were
found heterozygous for this substitution. Accord-
ingly, fumarase activity in parent’s lymphoblastoid
cell lines represented about 50% of mean control
activity, in both the mitochondrial and cytosolic com-
partments. Mutations of the fumarase cDNA were
 .since reported in six unrelated families Table 2 .
A mutation in the succinate flavoprotein subunit
cDNA has been reported in two sisters presenting
w xwith Leigh syndrome and SDH deficiency 3 . Both
patients were found homozygous for a Arg544Trp
substitution in a highly conserved domain of the SDH
cDNA. Both consanguineous parents were found het-
erozygous for this substitution. Expression of mutant
and wild-type SDH Fp cDNAs in enzyme-deficient
yeast strain confirmed the pathogenic character of
this substitution.
Our present knowledge on the molecular bases of
TCAC diseases is restricted to the cases mentioned
above.
Recessive inheritance of the mutations was noticed
in both of the cases of fumarase and SDH deficien-
w xcies which have been elucidated 2,3 . The consan-
guinity of the parents suggests a similar recessive
inheritance in the cases of a-KG dehydrogenase and
w xin most cases of fumarase deficiencies 16–18,34 .
Several patients presenting with SDH or fumarase
defect and born from unrelated parents have also
w xbeen reported 19–21,25,26,28,29 . Nevertheless, the
primary nature of these defects remains to be estab-
lished before assessing other modes of inheritances.
5. Conclusion
The recent elucidation of the molecular basis of
several TCAC enzyme deficiencies definitively estab-
lishes the occurrence of isolated and primary TCAC
deficiencies in man. This new group of diseases has
to be added to other known diseases affecting the
oxidative activities of the mitochondria, namely res-
piratory chain activity and fatty acid b-oxidation. No
clinical clue allows to easily distinguish between
these different diseases, the patients often presenting
with similar neuromuscular impairments. The disclo-
sure of anomalous urinary excretion of specific or-
ganic acids should however prompt investigation of
TCAC enzyme activities. Noticeably, an excretion of
organic acids, particularly of a-KG, is also fre-
quently observed in respiratory chain disorders, but
this generally does not specifically concern one unique
metabolite.
The investigation of the patients presenting with a
TCAC enzyme defect has revealed a surprising com-
plexity, the mechanism of which remains largely to
be established. Already, it teaches us that, as previ-
w xously suggested in animal 9 , the TCAC in human is
possibly organized around two distinct cycles, one of
which being potentially by-passed in vivo. This prob-
ably accounts for the normal respiration and survival
of enzyme-deficient cells in culture, as well as for the
several-years survival of most of these patients, de-
spite a life-threatening prognosis.
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